Biointaxis S.L. 

A spin-off biotech company developing a state-of-the-art gene therapy for Friedreich’s ataxia

OWNER

Antoni Matilla (See Profile)


Sector

Biotech

Stage

Prototyping, preclinical

Country

Spain


Unique product in reversing both neurological and cardiac deficits in FRDA

Unique in providing phisological expression of product for efficient treatment in FRDA

International patent (national phases)

Outstanding preclinical data

IP Type Status Time Countries Link Coverage
Patent Approved 25 years
  • Australia
  • Austria
  • Belgium
  • Canada
  • China
  • Denmark
  • Finland
  • France
  • Germany
  • Italy
  • Japan
  • Netherlands
  • Russia
  • South Korea
  • Spain
  • Switzerland
  • USA
  • United Kingdom
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2019076973 The present invention provides gene therapies for the treatment of Friedreich’s ataxia. Specifically, the present invention provides a nucleic acid, cloning vector and transfer vector for the production of an adeno-associated virus (AAV) vector. The nucleic acid comprises (i) a nucleic acid sequence encoding frataxin, (ii) a phospho-glycerate-kinase (PGK) promoter, and (iii) a woodchuck hepatitis virus posttranscriptional regulatory element (WPRE). The present invention also provides a pharmaceutical composition which comprises the AAV vector or nucleic acid. Also, the AAV vector, nucleic acid or pharmaceutical composition can be used as a medicament, specifically as a medicament for the treatment of Friedreich’s ataxia.

This information is confidential, do not share or copy.

Under evaluation at least till: 8th April

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2021 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar